Literature DB >> 14988379

Value of serum prolactin in the management of syncope.

S Ahmad1, M W Beckett.   

Abstract

OBJECTIVE: A meta-analysis of studies of the usefulness of raised serum prolactin in diagnosing generalised tonic-clonic seizures (GTCS) in patients presenting to the accident and emergency (A&E) department after a single episode of syncope.
METHODS: A three part question was defined. Medline, EMBASE, PubMed, the Cochrane Library were searched to identify relevant studies. Studies were evaluated for eligibility and quality and data extracted to calculate sensitivity (SN), specificity (SP), and likelihood ratios (LR).
RESULTS: Of 13 relevant studies only three met the criteria for evaluation. If a serum prolactin concentration is greater than three times the baseline when taken within one hour of syncope, then in the absence of test "modifiers": (1) the patient is nine times more likely to have suffered a GTCS as compared with a pseudoseizure positive LR = 8.92 (95% CI (1.31 to 60.91)), SN = 0.62 (95% CI (0.40 to 0.83)), SP = 0.89 (95% CI (0.60 to 0.98)) and (2) five times more likely to have suffered a GTCS as compared with non-convulsive syncope positive LR 4.60 (95% CI (1.25 to 16.90)), SN = 0.71 (95% CI (0.49 to 0.87)), SP = 0.85 (95% CI (0.55 to 0.98)).
CONCLUSION: A positive test result is highly predictive of a GTCS, however a negative test result does not necessarily exclude a seizure. Serum prolactin should be measured in patients presenting to the A&E department within an hour of a syncopal episode, unless the cause is immediately obvious.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988379      PMCID: PMC1726305          DOI: 10.1136/emj.2003.008870

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  19 in total

Review 1.  Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests.

Authors:  J J Deeks
Journal:  BMJ       Date:  2001-07-21

2.  Reciprocal control by the preoptic area of LH and prolactin.

Authors:  J A Clemens; C J Shaar; J W Kleber; W A Tandy
Journal:  Exp Brain Res       Date:  1971       Impact factor: 1.972

3.  Serum prolactin in epilepsy and hysteria.

Authors:  M R Trimble
Journal:  Br Med J       Date:  1978-12-16

4.  Differential response of growth hormone, cortisol, and prolactin to seizures and to stress.

Authors:  A Culebras; M Miller; L Bertram; J Koch
Journal:  Epilepsia       Date:  1987 Sep-Oct       Impact factor: 5.864

5.  The hormonal responses to generalized tonic-clonic seizures.

Authors:  M J Aminoff; R P Simon; E Wiedemann
Journal:  Brain       Date:  1984-06       Impact factor: 13.501

6.  Plasma prolactin concentrations following epileptic and pseudoseizures.

Authors:  W C Collins; O Lanigan; N Callaghan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

7.  Serum prolactin and cortisol concentrations after grand mal seizures.

Authors:  R J Abbott; M C Browning; D L Davidson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

8.  Serum prolactin and cortisol levels in evaluation of pseudoepileptic seizures.

Authors:  P B Pritchard; B B Wannamaker; J Sagel; C M Daniel
Journal:  Ann Neurol       Date:  1985-07       Impact factor: 10.422

9.  Prolactin changes after seizures classified by EEG monitoring.

Authors:  K D Laxer; J P Mullooly; B Howell
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

10.  Prolactin and growth hormone dynamics in epileptic patients receiving phenytoin.

Authors:  R D Elwes; C Dellaportas; E H Reynolds; W Robinson; W R Butt; D R London
Journal:  Clin Endocrinol (Oxf)       Date:  1985-09       Impact factor: 3.478

View more
  2 in total

1.  The discriminative value of blood gas analysis parameters in the differential diagnosis of transient disorders of consciousness.

Authors:  Karmele Olaciregui Dague; R Surges; J Litmathe; L Villa; J Brokmann; J B Schulz; M Dafotakis; O Matz
Journal:  J Neurol       Date:  2018-07-09       Impact factor: 4.849

2.  Epilepsy under my skin?

Authors:  Mark W L van Geffen; Hanneke M H Joosten; Patricia M Stassen
Journal:  BMJ Case Rep       Date:  2018-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.